ARCHIVES

Watson To Head Genome Research

This article is from The Cancer Letter archive.

Vol. 14 No. 38 | September 30, 1988

Download PDF Visit The Full Archive

Related Articles

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

April 29, 1988

NCI Director Halts STELLAR Trial, Seeks “Brilliant Ideas” For Breast Cancer Prevention.

March 2, 2007

NCI subsidy of $2 million paid major expenses of rescheduled meeting.

April 15, 2005

RFP: Sole Source

May 12, 2000

Schmidt’s Doubts Threaten Control Saturation Program

August 22, 1975

NCI Needs $107 Million More In FY 1982 Than Asked for Key Programs, R01s And P01s, New Initiatives

April 17, 1981